Guttalax

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

sodium picosulfate

Available from:

Istituto de Angeli S.R.L. Loc. Prulli

INN (International Name):

sodium picosulfate

Dosage:

7,5mg/ml

Pharmaceutical form:

drops oral

Prescription type:

OTC

Summary of Product characteristics

                                /fr\
Boehri
nser
\tlllrr
Ingelheirn
I.
NAMES
OF
THE
MEDICINALPRODUCTS
Guttalax$
7.5
rng/rnl
oral
drops
Prodnci
lnforrrrfition
2.
QUALITATTVEANDQUANTTTATWECOMPOSTTTON
Active
substance:
Sodium
picosulphate
Cunalaxs
7.5
mq/,:rrl
orql
clr-ops
I
Tlt:i"t,,9"
-!up.p*n.,
14
drops)
contains
7;78
mg
sodium picosulphate
monotrydrare (equivalent
to
/.)
mg
soclull
plsosutphate)
Ercipient
with
known
effecl:
sorbitol
(see
section
4,zt):
a',,,,,PEARAfAciItUTll,flL
SOflM
Guttalaxs
7,S--rng/rnl
oral
dropq
Laxative
drops,
.solution
'eohur-,less
to
yellowi$h,
olear
nol
io.n
4,
CLINTCALPARTICULARS
*i*l.'fh,gr*$uUlieindicr(tigirs
ilffiff,ffi*##'d
ll,ii.
tilri{f
if
li,,x*-E=
,6as:
z3
For
uie
in constipation
and
for
facilitation
of,defaecation
in
conditions
rvhere
this
is
required.
:
Aq
rvith
-other
laxatives,
Guttalaxs
7.5
rng/ml
oral
drops
should
not
be
taken
on
a
daily
basis
or
lbr
long
poriods
of
tirne
wi-thout
a
firll
diagnostic
evaluation
of
the
cause
of
the
csnstirration.
42
Posology
ancl
method
of
*dminlstration
Posplogy:
lltql
otherwise'preserib'6d,
th.e
adu:lt
dose
is,l:S.
l:g
{ysps.(eouivalent
ro
S
-
l0
rng
sodium
picosul-
phate).
The
dcse
for
children
aged
j
y:ars
ang
.lbqy*,
,,,riho
lhould
only
take
tlre
proiiuct
if
it
is
pr:es6ibed
by
a
doctor,
ia
5
-
9 drops
(equivalent
to-?;s -
5
mg
sodirrm
picosulphate)
It
is recomniended
lo
startwith
the
lowest
dose.
The
close
may
be
adjusted
up
to
the
maxirnunr
:e:omnl.elded
close
to
procluce
regularstools.
The
maximum
daily
dose
of
f
g
Uropr
ifoi
uJ'ufol
ot
9
drops
(for
childpn
aged 4
years
and above),
should
not
be exceeded.
futtarl,e
7.5
rnglml
rrral
drops
should-not
be
taken
on
a
conrinuous
daily
basis
or
fbr
long
periods
of
fime
without
investigating
the
qause
of
the
consripaticn,
Melhod
o.f
ad
mjnintrarion:
Oraluse
P'
,1,$fJ
Electrolyte
imbalance
rnay lead
to
increased
sensitivi6,
to
cardias:glycosides.
Concurrentadmirlislration
of
antibiotics
may
reduce
the
la.lotive
a[tion
of
Curtala,rs
7.5
mg/.ml
oral
dropS.
{,6
roffIitilJrysriry
e$t
tax$tffi
PEg[r.qncy:
&PF
Itil1'trB
q
/f
ad
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Russian 09-06-2017

Search alerts related to this product

View documents history